Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders.

Corti O, Blomgren K, Poletti A, Beart PM (2020) Autophagy in neurodegeneration: new insights underpinning therapy for neurological diseases. J Neurochem 154:354–371

pubmed: 32149395 doi: 10.1111/jnc.15002

Rodolfo C, Di Bartolomeo S, Cecconi F (2016) Autophagy in stem and progenitor cells. Cell Mol Life Sci 73:475–496. https://doi.org/10.1007/s00018-015-2071-3

doi: 10.1007/s00018-015-2071-3 pubmed: 26502349

Klionsky DJ, Codogno P, Cuervo AM, Deretic V, Elazar Z, Fueyo-Margareto J, Gewirtz DA, Kroemer G, Levine B, Mizushima N et al (2010) A comprehensive glossary of autophagy-related molecules and processes. Autophagy 6:438–448

pubmed: 20484971 doi: 10.4161/auto.6.4.12244

Lin Y, Huang Y, Chen L, Chu P (2015) Autophagy in cancer stem/progenitor cells. Cancer Chemother Pharmacol 75:879–886. https://doi.org/10.1007/s00280-014-2634-2

doi: 10.1007/s00280-014-2634-2 pubmed: 25424280

Guan J, Simon A, Prescott M, Menendez J, Liu F, Wang F, Wang C, Wolvetang E, Vazquez-Martin A, Zhang J (2013) Autophagy in stem cells. Autophagy 9:830–849. https://doi.org/10.4161/auto.24132

doi: 10.4161/auto.24132 pubmed: 23486312 pmcid: 3672294

Lei Y, Zhang D, Yu J, Dong H, Zhang J, Yang S (2017) Targeting autophagy in cancer stem cells as an anticancer therapy. Cancer Lett 393:33–39. https://doi.org/10.1016/j.canlet.2017.02.012

doi: 10.1016/j.canlet.2017.02.012 pubmed: 28216370

Guo JY, White E (2017) Autophagy, metabolism, and cancer. Cold Spring Harb Symp Quant Biol 81:73–78. https://doi.org/10.1101/sqb.2016.81.030981

doi: 10.1101/sqb.2016.81.030981 pmcid: 5521269 pubmed: 5521269

Hua F, Shang S, Hu ZW (2017) Seeking new anti-cancer agents from autophagy-regulating natural products. J Asian Nat Prod Res 19:305–313. https://doi.org/10.1080/10286020.2017.1304385

doi: 10.1080/10286020.2017.1304385 pubmed: 28347180

Jacob JA, Salmani JM, Jiang Z, Feng L, Song J, Jia X, Chen B (2017) Autophagy: an overview and its roles in cancer and obesity. Clin Chim Acta 468:85–89. https://doi.org/10.1016/j.cca.2017.01.028

doi: 10.1016/j.cca.2017.01.028 pubmed: 28153737

Chen K, Yuan R, Geng S, Zhang Y, Ran T, Kowalski E, Liu J, Li L (2017) Toll-interacting protein deficiency promotes neurodegeneration via impeding autophagy completion in high-fat diet-fed ApoE-/- mouse model. Brain Behav Immun 59:200–210. https://doi.org/10.1016/j.bbi.2016.10.002

doi: 10.1016/j.bbi.2016.10.002 pubmed: 27720815

Hwang CJ, Kim YE, Son DJ, Park MH, Choi DY, Park PH, Hellstrom M, Han SB, Oh KW, Park EK, Hong JT (2017) Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function. Redox Biol 11:456–468. https://doi.org/10.1016/j.redox.2016.12.008

doi: 10.1016/j.redox.2016.12.008 pubmed: 28086194

Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A et al (2017) Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93:1015–1034. https://doi.org/10.1016/j.neuron.2017.01.022

doi: 10.1016/j.neuron.2017.01.022 pubmed: 28279350

Plaza-Zabala A, Sierra-Torre V, Sierra A (2017) Autophagy and microglia: novel partners in neurodegeneration and aging. Int J Mol Sci 18:E598. https://doi.org/10.3390/ijms18030598

doi: 10.3390/ijms18030598 pubmed: 28282924

Yuan B, Shen H, Lin L, Su T, Zhong L, Yang Z (2017) Autophagy promotes microglia activation through Beclin-1-Atg5 pathway in intracerebral hemorrhage. Mol Neurobiol 54:115–124. https://doi.org/10.1007/s12035-015-9642-z

doi: 10.1007/s12035-015-9642-z pubmed: 26732594

Zhong Z, Sanchez-Lopez E, Karin M (2016) Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases. Clin Exp Rheumatol 34:12–16

pubmed: 27586797

Suh HW, Kim JK, Kim TS, Jo EK (2017) New insights into vitamin D and autophagy in inflammatory bowel diseases. Curr Med Chem 24:898–910. https://doi.org/10.2174/0929867323666161202151856

doi: 10.2174/0929867323666161202151856 pubmed: 27915989

Miettinen TP, Bjorklund M (2016) The mevalonate pathway as a metabolic requirement for autophagy-implications for growth control, proteostasis, and disease. Mol Cell Oncol 3:e1143546. https://doi.org/10.1080/23723556.2016.1143546

doi: 10.1080/23723556.2016.1143546 pubmed: 27314093 pmcid: 4909433

Jia G, Sowers JR (2015) Autophagy: a housekeeper in cardiorenal metabolic health and disease. Biochim Biophys Acta 1852:219–224. https://doi.org/10.1016/j.bbadis.2014.06.025

doi: 10.1016/j.bbadis.2014.06.025 pubmed: 24984281

Wang F, Jia J, Rodrigues B (2017) Autophagy, metabolic disease, and pathogenesis of heart dysfunction. Can J Cardiol 33:850–859. https://doi.org/10.1016/j.cjca.2017.01.002

doi: 10.1016/j.cjca.2017.01.002 pubmed: 28389131

Zhang S, Lin X, Li G, Shen X, Niu D, Lu G, Fu X, Chen Y, Cui M, Bai Y (2017) Knockout of Eva1a leads to rapid development of heart failure by impairing autophagy. Cell Death Dis 8:e2586. https://doi.org/10.1038/cddis.2017.17

doi: 10.1038/cddis.2017.17 pubmed: 28151473 pmcid: 5386466

Ren SY, Xu X (2015) Role of autophagy in metabolic syndrome-associated heart disease. Biochim Biophys Acta 1852:225–231. https://doi.org/10.1016/j.bbadis.2014.04.029

doi: 10.1016/j.bbadis.2014.04.029 pubmed: 24810277

Rubinsztein David C, Marino G, Kroemer G (2011) Autophagy and aging. Cell 146:682–695. https://doi.org/10.1016/j.cell.2011.07.030

doi: 10.1016/j.cell.2011.07.030 pubmed: 21884931

Mizushima N, Levine B (2010) Autophagy in mammalian development and differentiation. Nat Cell Biol 12:823–830. https://doi.org/10.1038/ncb0910-823

doi: 10.1038/ncb0910-823 pubmed: 20811354 pmcid: 3127249

Mizushima N, Komatsu M (2011) Autophagy: renovation of cells and tissues. Cell 147:728–741. https://doi.org/10.1016/j.cell.2011.10.026

doi: 10.1016/j.cell.2011.10.026 pubmed: 22078875

He L, Zhang J, Zhao J, Ma N, Kim SW, Qiao S et al (2018) Autophagy: the last defense against cellular nutritional stress. Adv Nutr Bethesda Md 9:493–504

doi: 10.1093/advances/nmy011

Doherty J, Baehrecke EH (2018) Life, death and autophagy. Nat Cell Biol 20:1110–1117

pubmed: 30224761 doi: 10.1038/s41556-018-0201-5

Xilouri M, Stefanis L (2010) Autophagy in the central nervous system: implications for neurodegenerative disorders. CNS Neurol Disord Drug Targets 9:701–719. https://doi.org/10.2174/187152710793237421

doi: 10.2174/187152710793237421 pubmed: 20942791

Cai Z, Zeng W, Tao K, Wang ZEB, Yang Q (2015) Chaperone mediated autophagy: roles in neuroprotection. Neurosci Bull 31:452–458. https://doi.org/10.1007/s12264-015-1540-x

doi: 10.1007/s12264-015-1540-x pubmed: 26206599 pmcid: 5563711

Kenney DL, Benarroch EE (2015) The autophagy-lysosomal pathway: general concepts and clinical implications. Neurology 85:634–645

pubmed: 26203091 doi: 10.1212/WNL.0000000000001860

Suzuki K, Ohsumi Y (2007) Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett 581:2156–2161

pubmed: 17382324 doi: 10.1016/j.febslet.2007.01.096

Tsukada M, Ohsumi Y (1993) Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett 333:169–174

pubmed: 8224160 doi: 10.1016/0014-5793(93)80398-E

Ogura K, Wicky C, Magnenat L, Tobler H, Mori I, Muller F et al (1994) Caenorhabditis elegans unc-51 gene required for axonal elongation encodes a novel serine/threonine kinase. Genes Dev 8:2389–2400

pubmed: 7958904 doi: 10.1101/gad.8.20.2389

Wang JL, Xu CJ (2020) Astrocytes autophagy in aging and neurodegenerative disorders. Biomed Pharmacother 122:109691

pubmed: 31786465 doi: 10.1016/j.biopha.2019.109691

Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R et al (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441:885–889

pubmed: 16625204 doi: 10.1038/nature04724

Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I et al (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441:880–884

pubmed: 16625205 doi: 10.1038/nature04723

Dice JF (1990) Peptide sequences that target cytosolic proteins for lysosomal proteolysis. Trends Biochem Sci 15:305–309

pubmed: 2204156 doi: 10.1016/0968-0004(90)90019-8

Kaushik S, Cuervo AM (2012) Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol 22:407–417

pubmed: 22748206 pmcid: 3408550 doi: 10.1016/j.tcb.2012.05.006

Parzych KR, Klionsky DJ (2014) An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal 20:460–473

pubmed: 23725295 pmcid: 3894687 doi: 10.1089/ars.2013.5371

Bauer PO, Goswami A, Wong HK, Okuno M, Kurosawa M, Yamada M et al (2010) Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein. Nat Biotechnol 28:256–263

pubmed: 20190739 doi: 10.1038/nbt.1608

Wang Y, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, Mandelkow E-M et al (2009) Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet 18:4153–4170

pubmed: 19654187 pmcid: 2758146 doi: 10.1093/hmg/ddp367

Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292–1295

pubmed: 15333840 doi: 10.1126/science.1101738

Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV et al (2008) Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 118:777–788

pubmed: 18172548 pmcid: 2157565

Kabuta T, Furuta A, Aoki S, Furuta K, Wada K (2008) Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy. J Biol Chem 283:23731–23738

pubmed: 18550537 pmcid: 3259779 doi: 10.1074/jbc.M801918200

Orenstein SJ, Kuo S-H, Tasset I, Arias E, Koga H, Fernandez-Carasa I et al (2013) Interplay of LRRK2 with chaperone-mediated autophagy. Nat Neurosci 16:394–406

pubmed: 23455607 pmcid: 3609872 doi: 10.1038/nn.3350

Sahu R, Kaushik S, Clement CC, Cannizzo ES, Scharf B, Follenzi A et al (2011) Microautophagy of cytosolic proteins by late endosomes. Dev Cell 20:131–139

pubmed: 21238931 pmcid: 3025279 doi: 10.1016/j.devcel.2010.12.003

Sharma M, Burre J, Bronk P, Zhang Y, Xu W, Sudhof TC (2012) CSPα knockout causes neurodegeneration by impairing SNAP-25 function. EMBO J 31:829–841

pubmed: 22187053 doi: 10.1038/emboj.2011.467

Uytterhoeven V, Lauwers E, Maes I, Miskiewicz K, Melo MN, Swerts J et al (2015) Hsc70–4 Deforms membranes to promote synaptic protein turnover by endosomal microautophagy. Neuron 88:735–748

pubmed: 26590345 doi: 10.1016/j.neuron.2015.10.012

Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H et al (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110:163–175

pubmed: 12150925 doi: 10.1016/S0092-8674(02)00808-5

Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y et al (2009) Nutrient dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell 20:1981–1991

pubmed: 19211835 pmcid: 2663915 doi: 10.1091/mbc.e08-12-1248

Mercer CA, Kaliappan A, Dennis PB (2009) A novel, human Atg13 binding protein, Atg101, interacts with ULK1 and is essential for macroautophagy. Autophagy 5:649–662

pubmed: 19287211 doi: 10.4161/auto.5.5.8249

Russell RC, Tian Y, Yuan H, Park HW, Chang Y-Y, Kim J et al (2013) ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 15:741–750

pubmed: 23685627 pmcid: 3885611 doi: 10.1038/ncb2757

Kabeya Y, Mizushima N, Yamamoto A, Oshitani-Okamoto S, Ohsumi Y, Yoshimori T (2004) LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation. J Cell Sci 117:2805–2812

pubmed: 15169837 doi: 10.1242/jcs.01131

Romanov J, Walczak M, Ibiricu I, Schuchner S, Ogris E, Kraft C et al (2012) Mechanism and functions of membrane binding by the Atg5-Atg12/Atg16 complex during autophagosome formation. EMBO J 31:4304–4317

pubmed: 23064152 pmcid: 3501226 doi: 10.1038/emboj.2012.278

Alemu EA, Lamark T, Torgersen KM, Birgisdottir AB, Larsen KB, Jain A et al (2012) ATG8 family proteins act as scaffolds for assembly of the ULK complex: sequence requirements for LC3-interacting region (LIR) motifs. J Biol Chem 287:39275–39290

pubmed: 23043107 pmcid: 3501051 doi: 10.1074/jbc.M112.378109

Rogov V, Dotsch V, Johansen T, Kirkin V (2014) Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell 53:167–178

pubmed: 24462201 doi: 10.1016/j.molcel.2013.12.014

Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS, Banfi S, Parenti G, Cattaneo E, Ballabio A (2009) A gene network regulating lysosomal biogenesis and function. Science 325:473–477

pubmed: 19556463 doi: 10.1126/science.1174447

Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, Sardiello M, Rubinsztein DC, Ballabio A (2011) TFEB links autophagy to lysosomal biogenesis. Science 332:1429–1433. https://doi.org/10.1126/science.1204592

doi: 10.1126/science.1204592 pubmed: 3638014 pmcid: 3638014

Kilpatrick K, Zeng Y, Hancock T, Segatori L (2015) Genetic and chemical activation of TFEB mediates clearance of aggregated α-synuclein. PLoS ONE 10:e0120819. https://doi.org/10.1371/journal.pone.0120819

doi: 10.1371/journal.pone.0120819 pubmed: 25790376 pmcid: 4366176

Martina JA, Diab HI, Lishu L, Jeong AL, Patange S, Raben N, Puertollano R (2014) The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal 7:ra9

pubmed: 24448649 pmcid: 4696865 doi: 10.1126/scisignal.2004754

Medina DL, Fraldi A, Bouche V, Annunziata F, Mansueto G, Spampanato C, Puri C, Pignata A, Martina JA, Sardiello M, Palmieri M, Polishchuk R, Puertollano R, Ballabio A (2011) Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev Cell 21:421–430

pubmed: 21889421 pmcid: 3173716 doi: 10.1016/j.devcel.2011.07.016

Cheli Y, Ohanna M, Ballotti R, Bertolotto C (2011) Fifteen-year quest for microphthalmia-associated transcription factor target genes. Pigment Cell Melanoma Res 23:27–40

doi: 10.1111/j.1755-148X.2009.00653.x

Ploper D, Taelman VF, Robert L, Perez BS, Titz B, Chen HW, Graeber TG, von Euw E, Ribas A, De Robertis EM (2015) MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. Proc Natl Acad Sci U S A 112:E420–E429

pubmed: 25605940 pmcid: 4321275 doi: 10.1073/pnas.1424576112

Perera RM, Stoykova S, Nicolay BN, Ross KN, Fitamant J, Boukhali M et al (2015) Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 524:361–365. https://doi.org/10.1038/nature14587

doi: 10.1038/nature14587 pubmed: 26168401 pmcid: 5086585

Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M, Ballabio A (2011) Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet 20:3852–3866

pubmed: 21752829 doi: 10.1093/hmg/ddr306

Chen S, Guo D, Lei B, Bi J, Yang H (2020) Biglycan protects human neuroblastoma cells from nitric oxide-induced death by inhibiting AMPK-mTOR mediated autophagy and intracellular ROS level. Biotechnol Lett 42:657–668

pubmed: 31989342 doi: 10.1007/s10529-020-02818-z

Ganley IG, Lam DH, Wang J, Ding X, Chen S, Jiang X (2009) ULK1·ATG13·FIP200 Complex mediates mTOR signaling and is essential for autophagy. J Biol Chem 284:12297–12305. https://doi.org/10.1074/jbc.M900573200

doi: 10.1074/jbc.M900573200 pubmed: 19258318 pmcid: 2673298

Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S-i Natsume T, Takehana K, Yamada N, Guan J-L, Oshiro N, Mizushima N (2009) Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy. Mol Biol Cell 20:1981–1991. https://doi.org/10.1091/mbc.E08-12-1248

doi: 10.1091/mbc.E08-12-1248 pubmed: 19211835 pmcid: 2663915

Jung CH, Jun CB, Ro S-H, Kim Y-M, Otto NM, Cao J, Kundu M, Kim D-H (2009) ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 20:1992–2003. https://doi.org/10.1091/mbc.E08-12-1249

doi: 10.1091/mbc.E08-12-1249 pubmed: 19225151 pmcid: 2663920

Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274–293. https://doi.org/10.1016/j.cell.2012.03.017

doi: 10.1016/j.cell.2012.03.017 pubmed: 22500797 pmcid: 3331679

Loffler AS, Alers S, Dieterle AM, Keppeler H, Franz-Wachtel M, Kundu M, Campbell DG, Wesselborg S, Alessi DR, Stork B (2011) Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop. Autophagy 7:696–706. https://doi.org/10.4161/auto.7.7.15451

doi: 10.4161/auto.7.7.15451 pubmed: 21460634

Kim J, Kundu M, Viollet B, Guan K-L (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132–141. https://doi.org/10.1038/ncb2152

doi: 10.1038/ncb2152 pubmed: 21258367 pmcid: 3987946

Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441:885–889. https://doi.org/10.1038/nature04724

doi: 10.1038/nature04724 pubmed: 16625204

Dooley Hannah C, Razi M, Polson Hannah E, Girardin Stephen E, Wilson Michael I, Tooze Sharon A (2014) WIPI2 Links LC3 conjugation with PI3P, autophagosome formation, and pathogen clearance by recruiting Atg12–5-16L1. Mol Cell 55:238–252. https://doi.org/10.1016/j.molcel.2014.05.021

doi: 10.1016/j.molcel.2014.05.021 pubmed: 24954904 pmcid: 4104028

Furuya N, Yu J, Byfield M, Pattingre S, Levine B (2005) The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 1:46–52. https://doi.org/10.4161/auto.1.1.1542

doi: 10.4161/auto.1.1.1542 pubmed: 16874027

Russell RC, Tian Y, Yuan H, Park HW, Chang Y-Y, Kim J, Kim H, Neufeld TP, Dillin A, Guan K-L (2013) ULK1 induces autophagy by phosphorylating Beclin-1 and activating Vps34 lipid kinase. Nat Cell Biol 15:741–750. https://doi.org/10.1038/ncb2757

doi: 10.1038/ncb2757 pubmed: 23685627 pmcid: 3885611

Dolzhenko E, van Vugt J, Shaw RJ, Bekritsky MA, van Blitterswijk M, Narzisi G, Ajay SS, Rajan V et al (2017) Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Res 27:1895–1903. https://doi.org/10.1101/gr.225672.117

doi: 10.1101/gr.225672.117 pubmed: 28887402 pmcid: 5668946

Wang S, Xia P, Rehm M, Fan Z (2015) Autophagy and cell reprogramming. Cell Mol Life Sci 72:1699–1713. https://doi.org/10.1007/s00018-014-1829-3

doi: 10.1007/s00018-014-1829-3 pubmed: 25572296

Bento CF, Renna M, Ghislat G, Puri C, Ashkenazi A, Vicinanza M, Menzies FM, Rubinsztein DC (2016) Mammalian autophagy: how does it work? Annu Rev Biochem 85:685–713. https://doi.org/10.1146/annurev-biochem-060815-014556

doi: 10.1146/annurev-biochem-060815-014556 pubmed: 26865532

Pankiv S, Clausen TH, Lamark T, Brech A, Bruun J-A, Outzen H, Overvatn A, Bjorkoy G, Johansen T (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282:24131–24145. https://doi.org/10.1074/jbc.m702824200

doi: 10.1074/jbc.m702824200 pubmed: 17580304

Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T (2005) p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171:603. https://doi.org/10.1083/jcb.200507002

doi: 10.1083/jcb.200507002 pubmed: 16286508 pmcid: 2171557

Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, Dotsch V, Bumann D, Dikic I (2011) Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 333:228–233. https://doi.org/10.1126/science.1205405

doi: 10.1126/science.1205405 pubmed: 21617041 pmcid: 3714538

Thurston TLM, Ryzhakov G, Bloor S, von Muhlinen N, Randow F (2009) The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 10:1215-U1103. https://doi.org/10.1038/ni.1800

doi: 10.1038/ni.1800 pubmed: 19820708

Kirkin V, Lamark T, Sou Y-S, Bjorkoy G, Nunn JL, Bruun J-A, Shvets E et al (2009) A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell 33:505–516. https://doi.org/10.1016/j.molcel.2009.01.020

doi: 10.1016/j.molcel.2009.01.020 pubmed: 19250911

Filimonenko M, Isakson P, Finley KD, Anderson M, Jeong H, Melia TJ, Bartlett BJ et al (2010) The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy. Mol Cell 38:265–279. https://doi.org/10.1016/j.molcel.2010.04.007

doi: 10.1016/j.molcel.2010.04.007 pubmed: 20417604 pmcid: 2867245

Mandell Michael A, Jain A, Arko-Mensah J, Chauhan S, Kimura T, Dinkins C, Silvestri G, Munch J, Kirchhoff F et al (2014) TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev Cell 30:394–409. https://doi.org/10.1016/j.devcel.2014.06.013

doi: 10.1016/j.devcel.2014.06.013 pubmed: 25127057 pmcid: 4146662

Jager S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P, Eskelinen E-L (2004) Role for Rab7 in maturation of late autophagic vacuoles. J Cell Sci 117:4837. https://doi.org/10.1242/jcs.01370

doi: 10.1242/jcs.01370 pubmed: 15340014

Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lullmann-Rauch R, Janssen PM, Blanz J, von Figura K, Saftig P (2000) Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406:902–906. https://doi.org/10.1038/35022595

doi: 10.1038/35022595 pubmed: 10972293

Epple UD, Suriapranata I, Eskelinen E-L, Thumm M (2001) Aut5/Cvt17p, a putative lipase essential for disintegration of autophagic bodies inside the vacuole. J Bacteriol 183:5942–5955. https://doi.org/10.1128/JB.183.20.5942-5955.2001

doi: 10.1128/JB.183.20.5942-5955.2001 pubmed: 11566994 pmcid: 99673

Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E (2005) Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 1:84–91. https://doi.org/10.4161/auto.1.2.1697

doi: 10.4161/auto.1.2.1697 pubmed: 16874052

Nah J, Yuan J, Jung YK (2015) Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach. Mol Cells 38:381–389. https://doi.org/10.14348/molcells.2015.0034

doi: 10.14348/molcells.2015.0034 pubmed: 25896254 pmcid: 4443278

Ravikumar B, Duden R, Rubinsztein DC (2002) Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 11:1107–1117. https://doi.org/10.1093/hmg/11.9.1107

doi: 10.1093/hmg/11.9.1107 pubmed: 11978769

Menzies FM, Fleming A, Rubinsztein DC (2015) Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci 16:345. https://doi.org/10.1038/nrn3961

doi: 10.1038/nrn3961 pubmed: 25991442

Puyal J, Ginet V, Grishchuk Y, Truttmann AC, Clarke PG (2012) Neuronal autophagy as a mediator of life and death: contrasting roles in chronic neurodegenerative and acute neural disorders. Neuroscientist 18:224–236. https://doi.org/10.1177/1073858411404948

doi: 10.1177/1073858411404948 pubmed: 21525331

Levine B, Kroemer G (2008) Autophagy in the pathogenesis of disease. Cell 132:27–42. https://doi.org/10.1016/j.cell.2007.12.018

doi: 10.1016/j.cell.2007.12.018 pubmed: 18191218 pmcid: 2696814

Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N (2013) Crosstalk between apoptosis, necrosis and autophagy. Biochim Biophys Acta 1833:3448–3459. https://doi.org/10.1016/j.bbamcr.2013.06.001

doi: 10.1016/j.bbamcr.2013.06.001 pubmed: 23770045

Son JH, Shim JH, Kim KH, Ha JY, Han JY (2012) Neuronal autophagy and neurodegenerative diseases. Exp Mol Med 44:89–98. https://doi.org/10.3858/emm.2012.44.2.031

doi: 10.3858/emm.2012.44.2.031 pubmed: 22257884 pmcid: 3296817

Martinet W, Agostinis P, Vanhoecke B, Dewaele M, De Meyer GR (2009) Autophagy in disease: a double-edged sword with therapeutic potential. Clin Sci 116:697–712. https://doi.org/10.1042/CS20080508

doi: 10.1042/CS20080508

Renna M, Jimenez-Sanchez M, Sarkar S, Rubinsztein DC (2010) Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem 285:11061–11067. https://doi.org/10.1074/jbc.R109.072181

doi: 10.1074/jbc.R109.072181 pubmed: 20147746 pmcid: 2856980

Mizushima N, Levine B, Cuervo AM, Klionsky DJ (2008) Autophagy fights disease through cellular self-digestion. Nature 451:1069–1075. https://doi.org/10.1038/nature06639

doi: 10.1038/nature06639 pubmed: 18305538 pmcid: 2670399

He C, Levine B (2010) The beclin 1 interactome. Curr Opin Cell Biol 22:140–149. https://doi.org/10.1016/j.ceb.2010.01.001

doi: 10.1016/j.ceb.2010.01.001 pubmed: 20097051 pmcid: 2854269

Markossian KA, Kurganov BI (2004) Protein folding, misfolding, and aggregation. Formation of inclusion bodies and aggresomes. Biochemistry 69:971–984. https://doi.org/10.1023/b%3Abiry.0000043539.07961.4c

doi: 10.1023/b%3Abiry.0000043539.07961.4c pubmed: 15521811

Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10:S10–S17. https://doi.org/10.1038/nm1066

doi: 10.1038/nm1066 pubmed: 15272267

Alzheimer’s A, (2016) 2016 Alzheimer’s disease facts and figures. Alzheimers Dement 12:459–509. https://doi.org/10.1016/j.jalz.2016.03.001

doi: 10.1016/j.jalz.2016.03.001

Liu X, Hou D, Lin F, Luo J, Xie J, Wang Y et al (2019) The role of neurovascular unit damage in the occurrence and development of Alzheimer’s disease. Rev Neurosci 30:477–484

pubmed: 30530893 doi: 10.1515/revneuro-2018-0056

Yoon S-Y, Kim D-H (2016) Alzheimer’s disease genes and autophagy. Brain Res 1649:201–209. https://doi.org/10.1016/j.brainres.2016.03.018

doi: 10.1016/j.brainres.2016.03.018 pubmed: 27016058

Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH et al (2005) Macroautophagy–a novel Beta-amyloid peptide-generating pathway activated in Alzheimer’s disease. J Cell Biol 171:87–98. https://doi.org/10.1083/jcb.200505082

doi: 10.1083/jcb.200505082 pubmed: 16203860 pmcid: 2171227

Hung SY, Huang WP, Liou HC, Fu WM (2009) Autophagy protects neuron from Abeta-induced cytotoxicity. Autophagy 5:502–510. https://doi.org/10.4161/auto.5.4.8096

doi: 10.4161/auto.5.4.8096 pubmed: 19270530

Wang H, Ma J, Tan Y, Wang Z, Sheng C, Chen S, Ding J (2010) Amyloid-beta1-42 induces reactive oxygen species-mediated autophagic cell death in U87 and SH-SY5Y cells. JAD 21:597–610. https://doi.org/10.3233/jad-2010-091207

doi: 10.3233/jad-2010-091207 pubmed: 20571221

Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM (2005) Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 64:113–122. https://doi.org/10.1093/jnen/64.2.113

doi: 10.1093/jnen/64.2.113 pubmed: 15751225

Nilsson P, Loganathan K, Sekiguchi M, Matsuba Y, Hui K, Tsubuki S, Tanaka M, Iwata N, Saito T, Saido Takaomi C (2013) Aβ secretion and plaque formation depend on autophagy. Cell Rep 5:61–69. https://doi.org/10.1016/j.celrep.2013.08.042

doi: 10.1016/j.celrep.2013.08.042 pubmed: 24095740

Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer’s disease. J Neurosci 28:6926–6937. https://doi.org/10.1523/JNEUROSCI.0800-08.2008

doi: 10.1523/JNEUROSCI.0800-08.2008 pubmed: 18596167 pmcid: 2676733

Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, Richardson A, Strong R, Galvan V (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of Alzheimer’s disease. PLoS ONE 5:e9979. https://doi.org/10.1371/journal.pone.0009979

doi: 10.1371/journal.pone.0009979 pubmed: 20376313 pmcid: 2848616

Tian Y, Bustos V, Flajolet M, Greengard P (2011) A small-molecule enhancer of autophagy decreases levels of Aβ and APP-CTF via Atg5-dependent autophagy pathway. FASEB J 25:1934–1942. https://doi.org/10.1096/fj.10-175158

doi: 10.1096/fj.10-175158 pubmed: 21368103 pmcid: 3101026

Vingtdeux V, Chandakkar P, Zhao H, d’Abramo C, Davies P, Marambaud P (2011) Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation. FASEB J 5:219–231. https://doi.org/10.1096/fj.10-167361

doi: 10.1096/fj.10-167361

Lee VMY, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121–1159. https://doi.org/10.1146/annurev.neuro.24.1.1121

doi: 10.1146/annurev.neuro.24.1.1121 pubmed: 11520930 pmcid: 11520930

Majid T, Ali YO, Venkitaramani DV, Jang M-K, Lu H-C, Pautler RG (2014) In vivo axonal transport deficits in a mouse model of fronto-temporal dementia. Neuroimage Clin 4:711–717. https://doi.org/10.1016/j.nicl.2014.02.005

doi: 10.1016/j.nicl.2014.02.005 pubmed: 24936422 pmcid: 4053640

Butzlaff M, Hannan SB, Karsten P, Lenz S, Ng J, Voßfeldt H, Prußing K, Pflanz R, Schulz JB, Rasse T, Voigt A (2015) Impaired retrograde transport by the Dynein/Dynactin complex contributes to Tau-induced toxicity. Hum Mol Genet 24:3623–3637. https://doi.org/10.1093/hmg/ddv107

doi: 10.1093/hmg/ddv107 pubmed: 25794683

Caccamo A, Majumder S, Richardson A, Strong R, Oddo S (2010) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-β, and Tau. J Biol Chem 285:13107–13120. https://doi.org/10.1074/jbc.m110.100420

doi: 10.1074/jbc.m110.100420 pubmed: 20178983 pmcid: 2857107

Berger Z, Ravikumar B, Menzies FM, Oroz LG, Underwood BR, Pangalos MN, Schmitt I, Wullner U, Evert BO, O’Kane CJ, Rubinsztein DC (2006) Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet 15:433–442. https://doi.org/10.1093/hmg/ddi458

doi: 10.1093/hmg/ddi458 pubmed: 16368705

Majumder S, Richardson A, Strong R, Oddo S (2011) Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS ONE 6:e25416. https://doi.org/10.1371/journal.pone.0025416

doi: 10.1371/journal.pone.0025416 pubmed: 21980451 pmcid: 3182203

Rodríguez-Navarro JA, Rodríguez L, Casarejos MJ, Solano RM, Gómez A, Perucho J, Cuervo AM, García de Yébenes J, Mena MA (2010) Trehalose ameliorates dopaminergic and tau pathology in parkin deleted/tau overexpressing mice through autophagy activation. Neurobiol Dis 39:423–438. https://doi.org/10.1016/j.nbd.2010.05.014

doi: 10.1016/j.nbd.2010.05.014 pubmed: 20546895

Schaeffer V, Lavenir I, Ozcelik S, Tolnay M, Winkler DT, Goedert M (2012) Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain 135:2169–2177. https://doi.org/10.1093/brain/aws143

doi: 10.1093/brain/aws143 pubmed: 22689910 pmcid: 3381726

Perez SE, He B, Nadeem M, Wuu J, Ginsberg SD, Ikonomovic MD, Mufson EJ (2015) Hippocampal endosomal, lysosomal and autophagic dysregulation in mild cognitive impairment: correlation with Aβ and Tau pathology. J Neuropathol Exp Neurol 74:345–358. https://doi.org/10.1097/NEN.0000000000000179

doi: 10.1097/NEN.0000000000000179 pubmed: 25756588

Collin L, Bohrmann B, Göpfert U, Oroszlan-Szovik K, Ozmen L, Grüninger F (2014) Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease. Brain 137:2834–2846. https://doi.org/10.1093/brain/awu213

doi: 10.1093/brain/awu213 pubmed: 25085375

Lee J-H, Yu WH, Kumar A, Lee S, Mohan PS, Peterhoff CM, Wolfe DM, Martinez-Vicente M, Massey AC, Sovak G, Uchiyama Y, Westaway D, Sisodia SS, Cuervo AM, Nixon RA (2010) Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141:1146–1158. https://doi.org/10.1016/j.cell.2010.05.008

doi: 10.1016/j.cell.2010.05.008 pubmed: 20541250 pmcid: 3647462

Bustos V, Pulina MV, Bispo A, Lam A, Flajolet M, Gorelick FS, Greengard P (2017) Phosphorylated Presenilin 1 decreases β-amyloid by facilitating autophagosome–lysosome fusion. Proc Natl Acad Sci USA 114:7148–7153. https://doi.org/10.1073/pnas.1705240114

doi: 10.1073/pnas.1705240114 pubmed: 28533369 pmcid: 5502640

Yang D-S, Stavrides P, Saito M, Kumar A, Rodriguez-Navarro JA, Pawlik M, Huo C, Walkley SU, Saito M, Cuervo AM, Nixon RA (2014) Defective macroautophagic turnover of brain lipids in the TgCRND8 Alzheimer mouse model: prevention by correcting lysosomal proteolytic deficits. Brain 137:3300–3318. https://doi.org/10.1093/brain/awu278

doi: 10.1093/brain/awu278 pubmed: 25270989 pmcid: 4240291

Tammineni P, Ye X, Feng T, Aikal D, Cai Q (2017) Impaired retrograde transport of axonal autophagosomes contributes to autophagic stress in Alzheimer’s disease neurons. Elife 6:e21776. https://doi.org/10.7554/eLife.21776

doi: 10.7554/eLife.21776 pubmed: 28085665 pmcid: 5235353

Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, Wyss-Coray T (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice. J Clin Invest 118:2190–2199. https://doi.org/10.1172/JCI33585

doi: 10.1172/JCI33585 pubmed: 18497889 pmcid: 2391284

Small Scott A, Kent K, Pierce A, Leung C, Kang Min S, Okada H, Honig L, Vonsattel JP, Kim TW (2005) Model-guided microarray implicates the retromer complex in Alzheimer’s disease. Ann Neurol 58:909–919. https://doi.org/10.1002/ana.20667

doi: 10.1002/ana.20667 pubmed: 16315276

Rohn TT, Wirawan E, Brown RJ, Harris JR, Masliah E, Vandenabeele P (2011) Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimer’s disease brain. Neurobiol Dis 43:68–78. https://doi.org/10.1016/j.nbd.2010.11.003

doi: 10.1016/j.nbd.2010.11.003 pubmed: 21081164

Pajares M, Jiménez-Moreno N, García-Yagüe ÁJ, Escoll M, de Ceballos ML, Van Leuven F, Rábano A, Yamamoto M, Rojo AI, Cuadrado A (2016) Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes. Autophagy 12:1902–1916. https://doi.org/10.1080/15548627.2016.1208889

doi: 10.1080/15548627.2016.1208889 pubmed: 27427974 pmcid: 5079676

Jo C, Gundemir S, Pritchard S, Jin YN, Rahman I, Johnson GVW (2014) Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nat Commun 5:3496–3496. https://doi.org/10.1038/ncomms4496

doi: 10.1038/ncomms4496 pubmed: 24667209

Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere M, Singh Pahwa J, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease, and shows evidence for additional susceptibility genes. Nat Genet 41:1088–1093. https://doi.org/10.1038/ng.440

doi: 10.1038/ng.440 pubmed: 19734902 pmcid: 2845877

Jun G, Naj AC, Beecham GW, Wang L-S, Buros J, Gallins PJ, Buxbaum JD, Ertekin-Taner N, Fallin MD, Friedland R et al (2010) Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer’s disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67:1473–1484. https://doi.org/10.1001/archneurol.2010.201

doi: 10.1001/archneurol.2010.201 pubmed: 20697030 pmcid: 3048805

Ando K, Brion J-P, Stygelbout V, Suain V, Authelet M, Dedecker R, Chanut A et al (2013) Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer’s brains. Acta Neuropathol 125:861–878. https://doi.org/10.1007/s00401-013-1111-z

doi: 10.1007/s00401-013-1111-z pubmed: 23589030

Ando K, Tomimura K, Sazdovitch V, Suain V, Yilmaz Z, Authelet M, Ndjim M, Vergara C, Belkouch M, Potier M-C, Duyckaerts C, Brion J-P (2016) Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease. Neurobiol Dis 94:32–43. https://doi.org/10.1016/j.nbd.2016.05.017

doi: 10.1016/j.nbd.2016.05.017 pubmed: 27260836

Moreau K, Fleming A, Imarisio S, Lopez Ramirez A, Mercer JL, Jimenez-Sanchez M, Bento CF, Puri C, Zavodszky E, Siddiqi F, Lavau CP et al (2014) PICALM modulates autophagy activity and tau accumulation. Nat Commun 5:4998. https://doi.org/10.1038/ncomms5998

doi: 10.1038/ncomms5998 pubmed: 25241929

Tian Y, Chang JC, Fan EY, Flajolet M, Greengard P (2013) Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer’s APP-CTF for terminal degradation via autophagy. Proc Natl Acad Sci USA 110:17071–17076. https://doi.org/10.1073/pnas.1315110110

doi: 10.1073/pnas.1315110110 pubmed: 24067654 pmcid: 3801056

Chen P, Wang Y, Chen L, Song N, Xie J (2020) Apelin-13 protects dopaminergic neurons against rotenone—induced neurotoxicity through the AMPK/mTOR/ULK-1 mediated autophagy activation. Int J Mol Sci 21:8376

pmcid: 7664695 doi: 10.3390/ijms21218376 pubmed: 7664695

Rocha EM, De Miranda B, Sanders LH (2018) Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease. Neurobiol Dis 109:249–257

pubmed: 28400134 doi: 10.1016/j.nbd.2017.04.004

Hewitt VL, Whitworth AJ (2017) Mechanisms of Parkinson’s disease: lessons from Drosophila. Curr Top Dev Biol 121:173–200

pubmed: 28057299 doi: 10.1016/bs.ctdb.2016.07.005

Dauer W, Przedborski S (2003) Parkinson’s disease: mechanisms and models. Neuron 39:889–909. https://doi.org/10.1016/s0896-6273(03)00568-3

doi: 10.1016/s0896-6273(03)00568-3 pubmed: 12971891

Moloudizargari M, Asghari MH, Ghobadi E, Fallah M, Rasouli S, Abdollahi M (2017) Autophagy, its mechanisms and regulation: Implications in neurodegenerative diseases. Ageing Res Rev 40:64–74. https://doi.org/10.1016/j.arr.2017.09.005

doi: 10.1016/j.arr.2017.09.005 pubmed: 28923312

Dehay B, Bové J, Rodríguez-Muela N, Perier C, Recasens A, Boya P, Vila M (2010) Pathogenic lysosomal depletion in Parkinson’s disease. J Neurosci 30:12535. https://doi.org/10.1523/jneurosci.1920-10.2010

doi: 10.1523/jneurosci.1920-10.2010 pubmed: 20844148 pmcid: 6633458

Bellomo G, Paciotti S, Gatticchi L, Parnetti L (2020) The vicious cycle between α- synuclein aggregation and autophagic-lysosomal dysfunction. Mov Disord Off J Mov Disord Soc 35:34–44

doi: 10.1002/mds.27895

Lin KJ, Lin KL, Chen SD, Liou CW, Chuang YC, Lin HY, Lin TK (2019) The overcrowded crossroads: mitochondria, alpha-synuclein, and the endo-lysosomal system interaction in Parkinson’s disease. Int J Mol Sci 20:5312

pmcid: 6862467 doi: 10.3390/ijms20215312 pubmed: 6862467

Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE (2013) α-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol 73:155–169. https://doi.org/10.1002/ana.23746

doi: 10.1002/ana.23746 pubmed: 23225525

Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC (2003) Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278:25009–25013. https://doi.org/10.1074/jbc.M300227200

doi: 10.1074/jbc.M300227200 pubmed: 12719433

Mak SK, McCormack AL, Manning-Boğ AB, Cuervo AM, Di Monte DA (2010) Lysosomal degradation of α-synuclein in vivo. J Biol Chem 285:13621–13629

pubmed: 20200163 pmcid: 2859524 doi: 10.1074/jbc.M109.074617

Vogiatzi T, Xilouri M, Vekrellis K, Stefanis L (2008) Wild type α-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells. J Biol Chem 283:23542–23556

pubmed: 18566453 pmcid: 2527094 doi: 10.1074/jbc.M801992200

Xilouri M, Brekk OR, Landeck N, Pitychoutis PM, Papasilekas T, Papadopoulou-Daifoti Z et al (2013) Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration. Brain 136:2130–2146

pubmed: 23757764 doi: 10.1093/brain/awt131

Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, Caballero C, Ferrer I, Obeso JA, Schapira AH (2010) Chaperone-mediated autophagy markers in Parkinson disease brains. Arch Neurol 67:1464–1472

pubmed: 20697033 doi: 10.1001/archneurol.2010.198

Sala G, Marinig D, Arosio A, Ferrarese C (2016) Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease. Front Mol Neurosci 9:157

pubmed: 28066181 pmcid: 5179559 doi: 10.3389/fnmol.2016.00157

Tang FL, Erion JR, Tian Y, Liu W, Yin DM, Ye J et al (2015) VPS35 in dopamine neurons is required for endosome-to-Golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for α-synuclein degradation and prevention of pathogenesis of Parkinson’s disease. J Neurosci 35:10613–10628

pubmed: 26203154 pmcid: 4510296 doi: 10.1523/JNEUROSCI.0042-15.2015

Murphy KE, Gysbers AM, Abbott SK, Tayebi N, Kim WS, Sidransky E et al (2014) Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease. Brain 137:834–848

pubmed: 24477431 pmcid: 3927701 doi: 10.1093/brain/awt367

Zhao L, Wang Z (2019) MicroRNAs: game changers in the regulation of α-Synuclein in Parkinson’s disease. Parkinson’s Disease 2019:1–10

Luan Y, Ren X, Zheng W, Zeng Z, Guo Y, Hou Z et al (2018) Chronic caffeine treatment protects against α-synucleinopathy by reestablishing autophagy activity in the mouse striatum. Frontiers in neuroscience 12:301

pubmed: 29770111 pmcid: 5942142 doi: 10.3389/fnins.2018.00301

Parekh P, Sharma N, Gadepalli A, Shahane A, Sharma M, Khairnar A (2019) A cleaning crew: the pursuit of autophagy in Parkinson’s disease. ACS chemical neuroscience 10:3914–3926

pubmed: 31385687 doi: 10.1021/acschemneuro.9b00244

Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R et al (2009) Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in α-synuclein models of Parkinson’s and Lewy body diseases. J Neurosci 29:13578–13588

pubmed: 19864570 pmcid: 2812014 doi: 10.1523/JNEUROSCI.4390-09.2009

Yan JQ, Yuan YH, Chu SF, Li GH, Chen NH (2018) E46K mutant α-synuclein is degraded by both proteasome and macroautophagy pathway. Molecules 23:2839

pmcid: 6278282 doi: 10.3390/molecules23112839 pubmed: 6278282

Salvador N, Aguado C, Horst M, Knecht E (2000) Import of a cytosolic protein into lysosomes by chaperone-mediated autophagy depends on its folding state. J Biol Chem 275:27447–27456

pubmed: 10862611 doi: 10.1016/S0021-9258(19)61529-2

Tanik SA, Schultheiss CE, Volpicelli-Daley LA, Brunden KR, Lee VM (2013) Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy. J Biol Chem 288:15194–15210

pubmed: 23532841 pmcid: 3663539 doi: 10.1074/jbc.M113.457408

Ahmed I, Liang Y, Schools S, Dawson VL, Dawson TM, Savitt JM (2012) Development and characterization of a new Parkinson’s disease model resulting from impaired autophagy. J Neurosci 32:16503–16509

pubmed: 23152632 pmcid: 3508432 doi: 10.1523/JNEUROSCI.0209-12.2012

Friedman LG, Lachenmayer ML, Wang J, He L, Poulose SM, Komatsu M et al (2012) Disrupted autophagy leads to dopaminergic axon and dendrite degeneration and promotes presynaptic accumulation of α-synuclein and LRRK2 in the brain. J Neurosci 32:7585–7593

pubmed: 22649237 pmcid: 3382107 doi: 10.1523/JNEUROSCI.5809-11.2012

Oueslati A, Schneider BL, Aebischer P, Lashuel HA (2013) Polo-like kinase 2 regulates selective autophagic α-synuclein clearance and suppresses its toxicity in vivo. Proc Natl Acad Sci 110:E3945–E3954

pubmed: 23983262 pmcid: 3799334 doi: 10.1073/pnas.1309991110

Tenreiro S, Reimao-Pinto MM, Antas P, Rino J, Wawrzycka D, Macedo D et al (2014) Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson’s disease. PLoS Genet 10:e1004302

pubmed: 24810576 pmcid: 4014446 doi: 10.1371/journal.pgen.1004302

Shahpasandzadeh H, Popova B, Kleinknecht A, Fraser PE, Outeiro TF, Braus GH (2014) Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions. J Biol Chem 289:31224–31240

pubmed: 25231978 pmcid: 4223324 doi: 10.1074/jbc.M114.559237

Sevlever D, Jiang P, Yen S-HC (2008) Cathepsin D is the main lysosomal enzyme involved in the degradation of α- synuclein and generation of its carboxy-terminally truncated species. Biochemistry 47:9678–9687

pubmed: 18702517 doi: 10.1021/bi800699v

Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P et al (2009) Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Molecular brain 2:1–17

doi: 10.1186/1756-6606-2-5

Miura E, Hasegawa T, Konno M, Suzuki M, Sugeno N, Fujikake N et al (2014) VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson’s disease. Neurobiol Dis 71:1–13

pubmed: 25107340 doi: 10.1016/j.nbd.2014.07.014

Zimprich A, Benet-Pagès A, Struhal W, Graf E, Eck SH, Offman MN et al (2011) A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. Am J Hum Genet 89:168–175

pubmed: 21763483 pmcid: 3135812 doi: 10.1016/j.ajhg.2011.06.008

Zavodszky E, Seaman MN, Moreau K, Jimenez-Sanchez M, Breusegem SY, Harbour ME, Rubinsztein DC (2014) Mutation in VPS35 associated with Parkinson’s disease impairs WASH complex association and inhibits autophagy. Nature Comm 5:1–16

doi: 10.1038/ncomms4828

Winslow AR, Chen C-W, Corrochano S, Acevedo-Arozena A, Gordon DE, Peden AA, Lichtenberg M, Menzies FM et al (2010) α-Synuclein impairs macroautophagy: implications for Parkinson’s disease. J Cell Biol 190:1023–1037. https://doi.org/10.1083/jcb.201003122

doi: 10.1083/jcb.201003122 pubmed: 20855506 pmcid: 3101586

Vekrellis K, Xilouri M, Emmanouilidou E, Rideout HJ, Stefanis L (2011) Pathological roles of α-synuclein in neurological disorders. Lancet Neurol 10:1015–1025

pubmed: 22014436 doi: 10.1016/S1474-4422(11)70213-7

Hou X, Watzlawik JO, Fiesel FC, Springer W (2020) Autophagy in Parkinson’s disease. J Mol Biol 432:2651–2672

pubmed: 32061929 pmcid: 7211126 doi: 10.1016/j.jmb.2020.01.037

Plowey ED, Cherra SJ III, Liu YJ, Chu CT (2008) Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells. J Neurochem 105:1048–1056

pubmed: 18182054 pmcid: 2361385 doi: 10.1111/j.1471-4159.2008.05217.x

Li JQ, Tan L, Yu JT (2014) The role of the LRRK2 gene in Parkinsonism. Mol Neurodegener 9:1–17

doi: 10.1186/1750-1326-9-1

Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L (2009) Abberant α-Synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS ONE 4:e5515. https://doi.org/10.1371/journal.pone.0005515

doi: 10.1371/journal.pone.0005515 pubmed: 19436756 pmcid: 2677735

Decressac M, Mattsson B, Weikop P, Lundblad M, Jakobsson J, Björklund A (2013) TFEB-mediated autophagy rescues midbrain dopamine neurons from α-synuclein toxicity. Proc Natl Acad Sci U S A 110:E1817–E1826. https://doi.org/10.1073/pnas.1305623110

doi: 10.1073/pnas.1305623110 pubmed: 23610405 pmcid: 3651458

Karabiyik C, Lee MJ, Rubinsztein DC (2017) Autophagy impairment in Parkinson’s disease. Essays Biochem 61:711–720. https://doi.org/10.1042/EBC20170023

doi: 10.1042/EBC20170023 pubmed: 29233880

Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52:205–210. https://doi.org/10.1002/ana.10279\

doi: 10.1002/ana.10279\ pubmed: 12210791

Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183:795–803. https://doi.org/10.1083/jcb.200809125

doi: 10.1083/jcb.200809125 pubmed: 19029340 pmcid: 2592826

Limanaqi F, Biagioni F, Busceti CL, Ryskalin L, Polzella M, Frati A, Fornai F (2019) Phytochemicals bridging autophagy induction and Alpha-Synuclein degradation in Parkinsonism. Int J Mol Sci 20:3274

pmcid: 6651086 doi: 10.3390/ijms20133274 pubmed: 6651086

Li G, Luo W, Wang B, Qian C, Ye Y, Li Y, Zhang S (2021) HMGA1 Induction of miR-103/107 forms a negative feedback loop to regulate autophagy in MPTP model of Parkinson’s disease. Front Cell Neurosci 14:464

Gil JM, Rego AC (2008) Mechanisms of neurodegeneration in Huntington’s disease. Eur J Neurosci 27:2803–2820. https://doi.org/10.1111/j.1460-9568.2008.06310.x

doi: 10.1111/j.1460-9568.2008.06310.x pubmed: 18588526

Martin JB, Gusella JF (1986) Huntington’s disease. Pathogenesis and management. N Engl J Med 315:1267–1276. https://doi.org/10.1056/NEJM198611133152006

doi: 10.1056/NEJM198611133152006 pubmed: 2877396

Imarisio S, Carmichael J, Korolchuk V, Chen C-W, Saiki S, Rose C, Krishna G, Davies Janet E, Ttofi E, Underwood Benjamin R, Rubinsztein David C (2008) Huntington’s disease: from pathology and genetics to potential therapies. Biochem J 412:191. https://doi.org/10.1042/BJ20071619

doi: 10.1042/BJ20071619 pubmed: 18466116

Jimenez-Sanchez M, Licitra F, Underwood BR, Rubinsztein DC (2017) Huntington’s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med 7:a024240. https://doi.org/10.1101/cshperspect.a024240

doi: 10.1101/cshperspect.a024240 pubmed: 27940602 pmcid: 5495055

Dayalu P, Albin RL (2015) Huntington disease: pathogenesis and treatment. Neurol Clin 33:101–114. https://doi.org/10.1016/j.ncl.2014.09.003

doi: 10.1016/j.ncl.2014.09.003 pubmed: 25432725

Tellez-Nagel I, Johnson AB, Terry RD (1974) Studies on brain biopsies of patients with Huntington’s chorea. J Neuropathol Exp Neurol 33:308–332. https://doi.org/10.1097/00005072-197404000-00008

doi: 10.1097/00005072-197404000-00008 pubmed: 4150800

Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O’Kane CJ, Rubinsztein DC (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36:585–595. https://doi.org/10.1038/ng1362

doi: 10.1038/ng1362 pubmed: 15146184

Martinez-Vicente M, Talloczy Z, Wong E, Tang GM, Koga H, Kaushik S, de Vries R, Arias E, Harris S, Sulzer D, Cuervo AM (2010) Cargo recognition failure is responsible for inefficient autophagy in Huntington’s disease. Nat Neurosci 13:567-U574. https://doi.org/10.1038/nn.2528

doi: 10.1038/nn.2528 pubmed: 20383138 pmcid: 2860687

Zheng S, Clabough EBD, Sarkar S, Futter M, Rubinsztein DC, Zeitlin SO (2010) Deletion of the Huntingtin polyglutamine stretch enhances neuronal autophagy and longevity in mice. PLoS Genet 6:e1000838. https://doi.org/10.1371/journal.pgen.1000838

doi: 10.1371/journal.pgen.1000838 pubmed: 20140187 pmcid: 2816686

Atwal RS, Truant R (2008) A stress sensitive ER membrane-association domain in Huntingtin protein defines a potential role for Huntingtin in the regulation of autophagy. Autophagy 4:91–93. https://doi.org/10.4161/auto.5201

doi: 10.4161/auto.5201 pubmed: 17986868

Rui Y-N, Xu Z, Patel B, Chen Z, Chen D, Tito A, David G, Sun Y, Stimming EF, Bellen HJ, Cuervo AM, Zhang S (2015) Huntingtin functions as a scaffold for selective macroautophagy. Nat Cell Biol 17:262–275. https://doi.org/10.1038/ncb3101

doi: 10.1038/ncb3101 pubmed: 25686248 pmcid: 4344873

Walter C, Clemens LE, Muller AJ, Fallier-Becker P, Proikas-Cezanne T, Riess O, Metzger S, Nguyen HP (2016) Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro. Neuropharmacology 108:24–38. https://doi.org/10.1016/j.neuropharm.2016.04.041

doi: 10.1016/j.neuropharm.2016.04.041 pubmed: 27133377

Squitieri F, Gellera C, Cannella M, Mariotti C, Cislaghi G, Rubinsztein DC, Almqvist EW, Turner D et al (2003) Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126:946–955. https://doi.org/10.1093/brain/awg077

doi: 10.1093/brain/awg077 pubmed: 12615650

Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC (2017) Polyglutamine tracts regulate beclin 1-dependent autophagy. Nature 545:108–111. https://doi.org/10.1038/nature22078

doi: 10.1038/nature22078 pubmed: 28445460 pmcid: 5420314

Sarkar S, Rubinsztein DC (2008) Huntington’s disease: degradation of mutant Huntingtin by autophagy. FEBS J 275:4263–4270. https://doi.org/10.1111/j.1742-4658.2008.06562.x

doi: 10.1111/j.1742-4658.2008.06562.x pubmed: 18637946

Wong YC, Holzbaur EL (2014) The regulation of autophagosome dynamics by Huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J Neurosci 34:1293–1305. https://doi.org/10.1523/jneurosci.1870-13.2014

doi: 10.1523/jneurosci.1870-13.2014 pubmed: 24453320 pmcid: 3898289

Martin DD, Ladha S, Ehrnhoefer DE, Hayden MR (2015) Autophagy in Huntington disease and huntingtin in autophagy. Trends Neurosci 38:26–35. https://doi.org/10.1016/j.tins.2014.09.003

doi: 10.1016/j.tins.2014.09.003 pubmed: 25282404

Lee H, Noh JY, Oh Y, Kim Y, Chang JW, Chung CW, Lee ST, Kim M, Ryu H, Jung YK (2012) IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux. Hum Mol Genet 21:101–114. https://doi.org/10.1093/hmg/ddr445

doi: 10.1093/hmg/ddr445 pubmed: 21954231

Ashkenazi A, Bento CF, Ricketts T, Vicinanza M, Siddiqi F, Pavel M, Squitieri F, Hardenberg MC, Imarisio S, Menzies FM, Rubinsztein DC (2017) Polyglutamine tracts regulate autophagy. Autophagy 13:1613–1614. https://doi.org/10.1080/15548627.2017.1336278

doi: 10.1080/15548627.2017.1336278 pubmed: 28722507 pmcid: 5612341

Matsumoto G, Wada K, Okuno M, Kurosawa M, Nukina N (2011) Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 44:279–289. https://doi.org/10.1016/j.molcel.2011.07.039

doi: 10.1016/j.molcel.2011.07.039 pubmed: 22017874

Al-Ramahi I, Giridharan S, Chen YC, Patnaik S, Safren N, Hasegawa J, de Haro M et al (2017) Inhibition of PIP4Kgamma ameliorates the pathological effects of mutant huntingtin protein. Elife 6:e29123. https://doi.org/10.7554/eLife.29123

doi: 10.7554/eLife.29123 pubmed: 29256861 pmcid: 5743427

Croce KR, Yamamoto A (2018) A role for autophagy in Huntington’s disease. Neurobiol Dis 122:16–22. https://doi.org/10.1016/j.nbd.2018.08.010

doi: 10.1016/j.nbd.2018.08.010 pubmed: 30149183 pmcid: 6364695

Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC (2007) Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant Huntingtin and α-Synuclein. J Biol Chem 282:5641–5652. https://doi.org/10.1074/jbc.M609532200

doi: 10.1074/jbc.M609532200 pubmed: 17182613

Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC (2005) Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170:1101–1111. https://doi.org/10.1083/jcb.200504035

doi: 10.1083/jcb.200504035 pubmed: 16186256 pmcid: 2171537

Jeong H, Then F, Melia TJ, Mazzulli JR, Cui L, Savas JN, Voisine C, Paganetti P, Tanese N, Hart AC, Yamamoto A, Krainc D (2009) Acetylation targets mutant Huntingtin to autophagosomes for degradation. Cell 137:60–72. https://doi.org/10.1016/j.cell.2009.03.018

doi: 10.1016/j.cell.2009.03.018 pubmed: 19345187 pmcid: 2940108

Qi L, Zhang XD, Wu JC, Lin F, Wang J, DiFiglia M, Qin ZH (2012) The role of chaperone-mediated autophagy in huntingtin degradation. PLoS One 7:e46834. https://doi.org/10.1371/journal.pone.0046834

doi: 10.1371/journal.pone.0046834 pubmed: 23071649 pmcid: 3469570

Hardiman O, van den Berg LH, Kiernan MC (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 7:639–649. https://doi.org/10.1038/nrneurol.2011.153

doi: 10.1038/nrneurol.2011.153 pubmed: 21989247

Andersen PM, Al-Chalabi A (2011) Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 7:603. https://doi.org/10.1038/nrneurol.2011.150

doi: 10.1038/nrneurol.2011.150 pubmed: 21989245

Blokhuis AM, Groen EJN, Koppers M, van den Berg LH, Pasterkamp RJ (2013) Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol 125:777–794. https://doi.org/10.1007/s00401-013-1125-6

doi: 10.1007/s00401-013-1125-6 pubmed: 23673820 pmcid: 3661910

Boillee S, Vande Velde C, Cleveland DW (2006) ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52:39–59. https://doi.org/10.1016/j.neuron.2006.09.018

doi: 10.1016/j.neuron.2006.09.018 pubmed: 17015226

Sasaki S (2011) Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 70:349–359. https://doi.org/10.1097/NEN.0b013e3182160690

doi: 10.1097/NEN.0b013e3182160690 pubmed: 21487309

Li L, Zhang X, Le W (2008) Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy 4:290–293. https://doi.org/10.4161/auto.5524

doi: 10.4161/auto.5524 pubmed: 18196963

Morimoto N, Nagai M, Ohta Y, Miyazaki K, Kurata T, Morimoto M, Murakami T, Takehisa Y, Ikeda Y, Kamiya T, Abe K (2007) Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res 1167:112–117. https://doi.org/10.1016/j.brainres.2007.06.045

doi: 10.1016/j.brainres.2007.06.045 pubmed: 17689501

Sheng YW, Chattopadhyay M, Whitelegge J, Valentine JS (2012) SOD1 Aggregation and ALS: role of metallation states and disulfide status. Curr Top Med Chem 12:2560–2572. https://doi.org/10.2174/15680266112129990079

doi: 10.2174/15680266112129990079 pubmed: 23339308

An T, Shi P, Duan W, Zhang S, Yuan P, Li Z, Wu D, Xu Z, Li C, Guo Y (2014) Oxidative stress and autophagic alteration in brainstem of SOD1-G93A mouse model of ALS. Mol Neurobiol 49:1435–1448. https://doi.org/10.1007/s12035-013-8623-3

doi: 10.1007/s12035-013-8623-3 pubmed: 24390572

Rudnick ND, Griffey CJ, Guarnieri P, Gerbino V, Wang X, Piersaint JA, Tapia JC, Rich MM, Maniatis T (2017) Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc Natl Acad Sci U S A 114:E8294–E8303. https://doi.org/10.1073/pnas.1704294114

doi: 10.1073/pnas.1704294114 pubmed: 28904095 pmcid: 5625902

Hetz C, Thielen P, Matus S, Nassif M, Court F, Kiffin R, Martinez G, Cuervo AM, Brown RH, Glimcher LH (2009) XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 23:2294–2306. https://doi.org/10.1101/gad.1830709

doi: 10.1101/gad.1830709 pubmed: 19762508 pmcid: 2758741

Crippa V, Sau D, Rusmini P, Boncoraglio A, Onesto E, Bolzoni E, Galbiati M, Fontana E, Marino M, Carra S, Bendotti C, De Biasi S, Poletti A (2010) The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet 19:3440–3456. https://doi.org/10.1093/hmg/ddq257

doi: 10.1093/hmg/ddq257 pubmed: 20570967

Gal J, Ström A-L, Kwinter DM, Kilty R, Zhang J, Shi P, Fu W, Wooten MW, Zhu H (2009) Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J Neurochem 111:1062–1073. https://doi.org/10.1111/j.1471-4159.2009.06388.x

doi: 10.1111/j.1471-4159.2009.06388.x pubmed: 19765191 pmcid: 2766427

Goode A, Butler K, Long J, Cavey J, Scott D, Shaw B, Sollenberger J, Gell C, Johansen T, Oldham NJ, Searle MS, Layfield R (2016) Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD. Autophagy 12:1094–1104. https://doi.org/10.1080/15548627.2016.1170257

doi: 10.1080/15548627.2016.1170257 pubmed: 27158844 pmcid: 4990988

Brady OA, Meng P, Zheng Y, Mao Y, Hu F (2011) Regulation of TDP-43 aggregation by phosphorylation andp62/SQSTM1. J Neurochem 116:248–259. https://doi.org/10.1111/j.1471-4159.2010.07098.x

doi: 10.1111/j.1471-4159.2010.07098.x pubmed: 21062285

Li F, Xie X, Wang Y, Liu J, Cheng X, Guo Y, Gong Y, Hu S, Pan L (2016) Structural insights into the interaction and disease mechanism of neurodegenerative disease-associated optineurin and TBK1 proteins. Nat Commun 7:12708. https://doi.org/10.1038/ncomms12708

doi: 10.1038/ncomms12708 pubmed: 27620379 pmcid: 5027247

Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, Dupont N et al (2012) TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 37:223–234. https://doi.org/10.1016/j.immuni.2012.04.015

doi: 10.1016/j.immuni.2012.04.015 pubmed: 22921120 pmcid: 3428731

Moore AS, Erika LFH (2016) Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc Natl Acad Sci U S A 113:E3349. https://doi.org/10.1073/pnas.1523810113

doi: 10.1073/pnas.1523810113 pubmed: 27247382 pmcid: 4914160

Sundaramoorthy V, Walker AK, Tan V, Fifita JA, Mccann EP, Williams KL, Blair IP, Guillemin GJ, Farg MA, Atkin JD (2015) Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis. Hum Mol Genet 24:3830–3846. https://doi.org/10.1093/hmg/ddv126

doi: 10.1093/hmg/ddv126 pubmed: 25859013

Tumbarello DA, Waxse BJ, Arden SD, Bright NA, Kendrick-Jones J, Buss F (2012) Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome. Nat Cell Biol 14:1024–1035. https://doi.org/10.1038/ncb2589

doi: 10.1038/ncb2589 pubmed: 23023224 pmcid: 3472162

Wong YC, Erika LFH (2014) Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci U S A 111:E4439. https://doi.org/10.1073/pnas.1405752111

doi: 10.1073/pnas.1405752111 pubmed: 25294927 pmcid: 4210283

Wong YC, Holzbaur ELF (2015) Temporal dynamics of PARK2/parkin and OPTN/optineurin recruitment during the mitophagy of damaged mitochondria. Autophagy 11:422–424. https://doi.org/10.1080/15548627.2015.1009792

doi: 10.1080/15548627.2015.1009792 pubmed: 25801386 pmcid: 4502688

Jantrapirom S, Lo PL, Yoshida H, Yamaguchi M (2018) Depletion of ubiquilin induces an augmentation in soluble ubiquitinated Drosophila TDP-43 to drive neurotoxicity in the fly. Biochim Biophys Acta Mol Basis Dis 1864:3038–3049. https://doi.org/10.1016/j.bbadis.2018.06.017

doi: 10.1016/j.bbadis.2018.06.017 pubmed: 29936333

Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, Yang Y et al (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477:211–215. https://doi.org/10.1038/nature10353

doi: 10.1038/nature10353 pubmed: 21857683 pmcid: 3169705

Le NT, Chang L, Kovlyagina I, Georgiou P, Safren N, Braunstein KE, Kvarta MD, Van Dyke AM, LeGates TA et al (2016) Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proc Natl Acad Sci U S A 113:E7580–E7589. https://doi.org/10.1073/pnas.1608432113

doi: 10.1073/pnas.1608432113 pubmed: 27834214 pmcid: 5127348

Chang L, Monteiro MJ (2015) Defective proteasome delivery of polyubiquitinated proteins by ubiquilin-2 proteins containing ALS mutations. PLoS One 10:e0130162. https://doi.org/10.1371/journal.pone.0130162

doi: 10.1371/journal.pone.0130162 pubmed: 26075709 pmcid: 4468220

Osaka M, Ito D, Suzuki N (2016) Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis-linked mutations in ubiquilin 2. Biochem Biophys Res Commun 472:324–331. https://doi.org/10.1016/j.bbrc.2016.02.107

doi: 10.1016/j.bbrc.2016.02.107 pubmed: 26944018

Todd TW, Petrucelli L (2016) Insights into the pathogenic mechanisms of chromosome 9 open reading frame 72 (C9orf72) repeat expansions. J Neurochem 138:145–162. https://doi.org/10.1111/jnc.13623

doi: 10.1111/jnc.13623 pubmed: 27016280

Webster CP, Smith EF, Bauer CS, Moller A, Hautbergue GM, Ferraiuolo L, Myszczynska MA, Higginbottom A et al (2016) The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J 35:1656–1676. https://doi.org/10.15252/embj.201694401

doi: 10.15252/embj.201694401 pubmed: 27334615 pmcid: 4969571

Sellier C, Campanari ML, Julie Corbier C, Gaucherot A, Kolb Cheynel I, Oulad Abdelghani M, Ruffenach F, Page A et al (2016) Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death. EMBO J 35:1276–1297. https://doi.org/10.15252/embj.201593350

doi: 10.15252/embj.201593350 pubmed: 27103069 pmcid: 4910533

Ji YJ, Ugolino J, Brady NR, Hamacher-Brady A, Wang J (2017) Systemic deregulation of autophagy upon loss of ALS- and FTD-linked C9orf72. Autophagy 13:1254–1255. https://doi.org/10.1080/15548627.2017.1299312

doi: 10.1080/15548627.2017.1299312 pubmed: 28319438 pmcid: 5529072

Chang MC, Srinivasan K, Friedman BA, Suto E, Modrusan Z, Lee WP, Kaminker JS, Hansen DV, Sheng M (2017) Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation. J Exp Med 214:2611–2628. https://doi.org/10.1084/jem.20160999

doi: 10.1084/jem.20160999 pubmed: 28778989 pmcid: 5584112

Ser A, Vollrath JT, Sechi A, Johann S, Roos A, Yamoah A, Katona I, Bohlega S, Wiemuth D, Tian Y et al (2017) The ALS-linked E102Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ 24:1655–1671. https://doi.org/10.1038/cdd.2017.88

doi: 10.1038/cdd.2017.88

Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, Gibbs JR et al (2010) Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron 68:857–864. https://doi.org/10.1016/j.neuron.2010.11.036

doi: 10.1016/j.neuron.2010.11.036 pubmed: 21145000 pmcid: 3032425

Watts GDJ, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, Pestronk A, Whyte MP, Kimonis VE (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36:377–381. https://doi.org/10.1038/ng1332

doi: 10.1038/ng1332 pubmed: 15034582

Johnson AE, Shu H, Hauswirth AG, Tong A, Davis GW (2015) VCP-dependent muscle degeneration is linked to defects in a dynamic tubular lysosomal network in vivo. Elife 4:e07366. https://doi.org/10.7554/eLife.07366

doi: 10.7554/eLife.07366 pmcid: 4574298 pubmed: 4574298

Kustermann M, Manta L, Paone C, Kustermann J, Lausser L, Wiesner C, Eichinger L et al (2018) Loss of the novel Vcp (valosin containing protein) interactor Washc4 interferes with autophagy-mediated proteostasis in striated muscle and leads to myopathy in vivo. Autophagy 14:1911–1927. https://doi.org/10.1080/15548627.2018.1491491

doi: 10.1080/15548627.2018.1491491 pubmed: 30010465 pmcid: 6152520

Ritson GP, Custer SK, Freibaum BD, Guinto JB, Geffel D, Moore J et al (2010) TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci 30:7729–7739. https://doi.org/10.1523/jneurosci.5894-09.2010

doi: 10.1523/jneurosci.5894-09.2010 pubmed: 20519548 pmcid: 2890254

Caccamo A, Maldonado MA, Majumder S, Medina DX, Holbein W, Magrí A, Oddo S (2011) Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. J Biol Chem 286:8924–8932. https://doi.org/10.1074/jbc.M110.180638

doi: 10.1074/jbc.M110.180638 pubmed: 21266573 pmcid: 3058958

Tanji K, Miki Y, Ozaki T, Maruyama A, Yoshida H, Mimura J, Wakabayashi K (2014) Phosphorylation of serine 349 of p62 in Alzheimer’s disease brain. Acta Neuropathol Commun 2:50. https://doi.org/10.1186/2051-5960-2-50

doi: 10.1186/2051-5960-2-50 pubmed: 24886973 pmcid: 4035093

Isakson P, Holland P, Simonsen A (2013) The role of ALFY in selective autophagy. Cell Death Differ 20:12–20. https://doi.org/10.1038/cdd.2012.66

doi: 10.1038/cdd.2012.66 pubmed: 22653340

Lim J, Lachenmayer ML, Wu S, Liu W, Kundu M, Wang R, Yue Z (2015) Proteotoxic stress induces phosphorylation of p62/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates. PLoS Genetics 11:e1004987. https://doi.org/10.1371/journal.pgen.1004987

doi: 10.1371/journal.pgen.1004987 pubmed: 25723488 pmcid: 4344198

Xilour M, Vogiatzi T, Stefanis L (2008) Alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson’s disease pathogenesis. Autophagy 4:917–919. https://doi.org/10.4161/auto.6685

doi: 10.4161/auto.6685

Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Kubisch C (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet 38:1184–1191. https://doi.org/10.1038/ng1884

doi: 10.1038/ng1884 pubmed: 16964263

Di Fonzo A, Chien HF, Socal M, Giraudo S, Tassorelli C, Iliceto G, Bonifati V (2007) ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 68:1557–1562. https://doi.org/10.1212/01.wnl.0000260963.08711.08

doi: 10.1212/01.wnl.0000260963.08711.08 pubmed: 17485642

Nixon RA, Yang DS (2012) Autophagy and neuronal cell death in neurological disorders. Cold Spring Harb Perspect Biol 4(10):a008839. https://doi.org/10.1101/cshperspect.a008839

doi: 10.1101/cshperspect.a008839 pubmed: 22983160 pmcid: 3475163

Gasser T (2009) Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev Mol Med 11:e22. https://doi.org/10.1017/S1462399409001148

doi: 10.1017/S1462399409001148 pubmed: 19631006

Kim YC, Guan KL (2015) mTOR: a pharmacologic target for autophagy regulation. J Clin Invest 125:25–32

pubmed: 25654547 pmcid: 4382265 doi: 10.1172/JCI73939

Du J, Liang Y, Xu F, Sun B, Wang Z (2013) Trehalose rescues Alzheimer’s disease phenotypes in APP/PS1 transgenic mice. J Pharm Pharmacol 65:1753–1756

pubmed: 24236985 doi: 10.1111/jphp.12108

Son SM, Shin H-J, Byun J, Kook SY, Moon M, Chang YJ et al (2016) Metformin facilitates amyloid-β generation by β- and γ-secretases via autophagy activation. J Alzheimers Dis JAD 51:1197–1208

pubmed: 26967226 doi: 10.3233/JAD-151200

Castillo K, Nassif M, Valenzuela V, Rojas F, Matus S, Mercado G et al (2013) Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons. Autophagy 9:1308–1320

pubmed: 23851366 doi: 10.4161/auto.25188

Li Y, Guo Y, Wang X, Yu X, Duan W, Hong K et al (2015) Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model. Neuroscience 298:12–25

pubmed: 25841320 doi: 10.1016/j.neuroscience.2015.03.061

Zhang X, Chen S, Song L, Tang Y, Shen Y, Jia L et al (2014) MTOR-independent, autophagic enhancer trehalose prolongs motor neuron survival and ameliorates the autophagic flux defect in a mouse model of amyotrophic lateral sclerosis. Autophagy 10:588–602

pubmed: 24441414 pmcid: 4091147 doi: 10.4161/auto.27710

Ma TC, Buescher JL, Oatis B, Funk JA, Nash AJ, Carrier RL et al (2007) Metformin therapy in a transgenic mouse model of Huntington’s disease. Neurosci Lett 411:98–103

pubmed: 17110029 doi: 10.1016/j.neulet.2006.10.039

Suresh SN, Chavalmane AK, Pillai M, Ammanathan V, Vidyadhara DJ, Yarreiphang H et al (2018) Modulation of autophagy by a small molecule inverse agonist of ERRα is neuroprotective. Front Mol Neurosci 11:109

pubmed: 29686608 pmcid: 5900053 doi: 10.3389/fnmol.2018.00109

Rose C, Menzies FM, Renna M, Acevedo-Arozena A, Corrochano S, Sadiq O et al (2010) Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington’s disease. Hum Mol Genet 19:2144–2153

pubmed: 20190273 pmcid: 2865373 doi: 10.1093/hmg/ddq093

Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH et al (2008) Novel targets for Huntington’s disease in an mTOR-independent Autophagy pathway. Nat Chem Biol 4:295–305

pubmed: 18391949 pmcid: 2635566 doi: 10.1038/nchembio.79

Hirano K, Fujimaki M, Sasazawa Y, Yamaguchi A, Ishikawa K-I, Miyamoto K et al (2019) Neuroprotective effects of memantine via enhancement of autophagy. Biochem Biophys Res Commun 518:161–170

pubmed: 31431260 doi: 10.1016/j.bbrc.2019.08.025

Chu C, Zhang X, Ma W, Li L, Wang W, Shang L, Fu P (2013) Induction of autophagy by a novel small molecule improves abeta pathology and ameliorates cognitive deficits. PLoS One 8:e65367. https://doi.org/10.1371/journal.pone.0065367

doi: 10.1371/journal.pone.0065367 pubmed: 23750258 pmcid: 3672196

Guo X, Lv J, Lu J, Fan L, Huang X, Hu L, Wang J, Shen X (2018) Protopanaxadiol derivative DDPU improves behavior and cognitive deficit in AD mice involving regulation of both ER stress and autophagy. Neuropharmacology 130:77–91. https://doi.org/10.1016/j.neuropharm.2017.11.033

doi: 10.1016/j.neuropharm.2017.11.033 pubmed: 29197516

Huang M, Jiang X, Liang Y, Liu Q, Chen S, Guo Y (2017) Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of beta-amyloid in APP/tau/PS1 mouse model of Alzheimer’s disease. Exp Gerontol 91:25–33. https://doi.org/10.1016/j.exger.2017.02.004

doi: 10.1016/j.exger.2017.02.004 pubmed: 28223223

Li LS, Lu YL, Nie J, Xu YY, Zhang W, Yang WJ, Gong QH, Lu YF, Lu Y, Shi JS (2017) Dendrobium nobile Lindl alkaloid, a novel autophagy inducer, protects against axonal degeneration induced by Abeta25-35 in hippocampus neurons in vitro. CNS Neurosci Ther 23:329–340. https://doi.org/10.1111/cns.12678

doi: 10.1111/cns.12678 pubmed: 28261990 pmcid: 6492701

Jiang T-F, Zhang Y-J, Zhou H-Y, Wang H-M, Tian L-P, Liu J, Ding J-Q, Chen S-D (2013) Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson’s disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy. J Neuroimmune Pharmacol 8:356–369. https://doi.org/10.1007/s11481-012-9431-7

doi: 10.1007/s11481-012-9431-7 pubmed: 23325107

Wu Y, Li X, Zhu JX, Xie W, Le W, Fan Z, Jankovic J, Pan T (2011) Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson’s disease. Neurosignals 19:163–174. https://doi.org/10.1159/000328516

doi: 10.1159/000328516 pubmed: 21778691 pmcid: 3699815

Lan D-M, Liu F-T, Zhao J, Chen Y, Wu J-J, Ding Z-T, Yue Z-Y, Ren H-M, Jiang Y-P, Wang J (2012) Effect of trehalose on PC12 cells overexpressing wild-type or A53T mutant α-synuclein. Neurochem Res 37:2025–2032. https://doi.org/10.1007/s11064-012-0823-0

doi: 10.1007/s11064-012-0823-0 pubmed: 22707286

Hebron ML, Lonskaya I, Moussa CEH (2013) Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson’s disease models. Hum Mol Genet 22:3315–3328. https://doi.org/10.1093/hmg/ddt192

doi: 10.1093/hmg/ddt192 pubmed: 23666528 pmcid: 3723316

Liu J, Chen M, Wang X, Wang Y, Duan C, Gao G, Lu L, Wu X, Wang X, Yang H (2016) Piperine induces autophagy by enhancing protein phosphotase 2A activity in a rotenone-induced Parkinson’s disease model. Oncotarget 7:60823–60843. https://doi.org/10.18632/oncotarget.11661

doi: 10.18632/oncotarget.11661 pubmed: 27572322 pmcid: 5308619

Hou YS, Guan JJ, Xu HD, Wu F, Sheng R, Qin ZH (2015) Sestrin2 protects dopaminergic cells against rotenone toxicity through AMPK-dependent autophagy activation. Mol Cell Biol 35:2740–2751. https://doi.org/10.1128/MCB.00285-15

doi: 10.1128/MCB.00285-15 pubmed: 26031332 pmcid: 4508325

Yang G, Li J, Cai Y, Yang Z, Li R, Fu W (2018) Glycyrrhizic acid alleviates 6-hydroxydopamine and corticosterone-induced neurotoxicity in SH-SY5Y cells through modulating autophagy. Neurochem Res 43:1914–1926. https://doi.org/10.1007/s11064-018-2609-5

doi: 10.1007/s11064-018-2609-5 pubmed: 30206804

Jang W, Ju Kim H, Li H, Jo K, Kyu Lee M, Hong Song S, Ok Yang H (2014) 1,25-Dyhydroxyvitamin D-3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy. Biochem Biophys Res Commun 451:142–147. https://doi.org/10.1016/j.bbrc.2014.07.081

doi: 10.1016/j.bbrc.2014.07.081 pubmed: 25078626

Jia H, Kast RJ, Steffan JS, Thomas EA (2012) Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington’s disease mice: implications for the ubiquitin–proteasomal and autophagy systems. Hum Mol Genet 21:5280–5293. https://doi.org/10.1093/hmg/dds379

doi: 10.1093/hmg/dds379 pubmed: 22965876 pmcid: 3510756

Abd-Elrahman KS, Hamilton A, Hutchinson SR, Liu F, Russell RC, Ferguson SSG (2017) mGluR5 antagonism increases autophagy and prevents disease progression in the zQ175 mouse model of Huntington’s disease. Sci Signal 10:eaan6387. https://doi.org/10.1126/scisignal.aan6387

doi: 10.1126/scisignal.aan6387 pubmed: 29259100

Chang C-C, Lin T-C, Ho H-L, Kuo C-Y, Li H-H, Korolenko TA, Chen W-J, Lai T-J, Ho Y-J, Lin C-L (2018) GLP-1 analogue liraglutide attenuates mutant Huntingtin-induced neurotoxicity by restoration of neuronal insulin signaling. Int J Mol Sci 19:2505. https://doi.org/10.3390/ijms19092505

doi: 10.3390/ijms19092505 pmcid: 6164932 pubmed: 6164932

Wong VKW, Wu AG, Wang JR, Liu L, Law BY-K (2015) Neferine attenuates the protein level and toxicity of mutant huntingtin in PC-12 cells via induction of autophagy. Molecules 20:3496–3514. https://doi.org/10.3390/molecules20033496

doi: 10.3390/molecules20033496 pubmed: 25699594 pmcid: 6272412

Wang IF, Guo BS, Liu YC, Wu CC, Yang CH, Tsai KJ, Shen CKJ (2012) Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Proc Natl Acad Sci U S A 109:15024–15029. https://doi.org/10.1073/pnas.1206362109

doi: 10.1073/pnas.1206362109 pubmed: 22932872 pmcid: 3443184

Wang Y, Chen S, Wang Z, Zhang X, Yang D, Zhang X, Li L, Le W (2011) Rapamycin treatment augments motor neuron degeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Autophagy 7:412–425

pubmed: 21193837 doi: 10.4161/auto.7.4.14541

Feng HL, Leng Y, Ma CH, Zhang J, Ren M, Chuang DM (2008) Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mouse model. Neuroscience 155:567–572. https://doi.org/10.1016/j.neuroscience.2008.06.040

doi: 10.1016/j.neuroscience.2008.06.040 pubmed: 18640245

Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, Lazzeri G et al (2008) Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 105:2052–2057. https://doi.org/10.1073/pnas.0708022105

doi: 10.1073/pnas.0708022105 pubmed: 18250315 pmcid: 2538879

Chang C-F, Lee Y-C, Lee K-H, Lin H-C, Chen C-L, Shen C-KJ, Huang C-C (2016) Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS. J Biomed Sci 23:72–72. https://doi.org/10.1186/s12929-016-0290-z

doi: 10.1186/s12929-016-0290-z pubmed: 27769241 pmcid: 5073438

Sun J, Mu Y, Jiang Y, Song R, Yi J, Zhou J, Sun J, Jiao X, Prinz RA, Li Y, Xu X (2018) Inhibition of p70 S6 kinase activity by A77 1726 induces autophagy and enhances the degradation of superoxide dismutase 1 (SOD1) protein aggregates. Cell Death Dis 9:407–407. https://doi.org/10.1038/s41419-018-0441-0

doi: 10.1038/s41419-018-0441-0 pubmed: 29540819 pmcid: 5851998

Zhou Q-M, Zhang J-J, Li S, Chen S, Le W-D (2017) n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1G93A mouse model of amyotrophic lateral sclerosis. CNS Neurosci Ther 23:375–385. https://doi.org/10.1111/cns.12681

doi: 10.1111/cns.12681 pubmed: 28229532 pmcid: 6492644

Exploring the Role of Autophagy Dysfunction in Neurodegenerative Disorders.

Journal

Informations de publication

Résumé

Identifiants

Substances chimiques

Types de publication

Langues

Sous-ensembles de citation

Pagination

Informations de copyright

Références

Auteurs

Tarapati Rana (T)

Tapan Behl (T)

Aayush Sehgal (A)

Vineet Mehta (V)

Sukhbir Singh (S)

Saurabh Bhatia (S)

Ahmed Al-Harrasi (A)

Simona Bungau (S)

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Smoking Cessation and Incident Cardiovascular Disease.

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Classifications MeSH